Terms: = Liver cancer AND CREBBP, CBP, 1387, ENSG00000005339, RSTS, RTS
131 results:
1. Psilostachyin C reduces malignant properties of hepatocellular carcinoma cells by blocking crebbp-mediated transcription of GATAD2B.
Jiang K; Ning N; Huang J; Chang Y; Wang R; Ma J
Funct Integr Genomics; 2024 Apr; 24(2):75. PubMed ID: 38600341
[TBL] [Abstract] [Full Text] [Related]
2. Plasma extracellular vesicle microRNAs reflecting the therapeutic effect of the cbp/β-catenin inhibitor PRI-724 in patients with liver cirrhosis.
Yoshida M; Matsuzaki J; Fujita K; Kimura M; Umezu T; Tokuda N; Yamaguchi T; Kuroda M; Ochiya T; Saito Y; Kimura K
Sci Rep; 2024 Mar; 14(1):6266. PubMed ID: 38491114
[TBL] [Abstract] [Full Text] [Related]
3. A multicenter, randomized phase 2 study to establish combinations of cbp501, cisplatin and nivolumab for ≥3rd-line treatment of patients with advanced pancreatic adenocarcinoma.
Enzler T; Nguyen A; Misleh J; Cline VJ; Johns M; Shumway N; Paulson S; Siegel R; Larson T; Messersmith W; Richards D; Chaves J; Pierce E; Zalupski M; Sahai V; Orr D; Ruste SA; Haun A; Kawabe T
Eur J Cancer; 2024 Apr; 201():113950. PubMed ID: 38422585
[TBL] [Abstract] [Full Text] [Related]
4. Discovery of Novel PROTAC Degraders of p300/cbp as Potential Therapeutics for Hepatocellular Carcinoma.
Chang Q; Li J; Deng Y; Zhou R; Wang B; Wang Y; Zhang M; Huang X; Li Y
J Med Chem; 2024 Feb; 67(4):2466-2486. PubMed ID: 38316017
[TBL] [Abstract] [Full Text] [Related]
5. Exploration of the Pharmacological Mechanism of Vitexicarpin against Triple-Negative Breast cancer in Network Pharmacology.
Wu T; Xiang M; Li Y; Gao Y; Teng D; Sun M; Guo W; Zhou Y
Front Biosci (Landmark Ed); 2023 Dec; 28(12):341. PubMed ID: 38179762
[TBL] [Abstract] [Full Text] [Related]
6. Can incorporating genotyping data into efficacy estimators improve efficiency of early phase malaria vaccine trials?
Potter GE; Callier V; Shrestha B; Joshi S; Dwivedi A; Silva JC; Laurens MB; Follmann DA; Deye GA
Malar J; 2023 Dec; 22(1):383. PubMed ID: 38115002
[TBL] [Abstract] [Full Text] [Related]
7. Association of Age With Treatment-Related Adverse Events and Survival in Patients With Metastatic Colorectal cancer.
Meng L; Thapa R; Delgado MG; Gomez MF; Ji R; Knepper TC; Hubbard JM; Wang X; Permuth JB; Kim RD; Laber DA; Xie H
JAMA Netw Open; 2023 Jun; 6(6):e2320035. PubMed ID: 37358854
[TBL] [Abstract] [Full Text] [Related]
8. LKB1 controls inflammatory potential through CRTC2-dependent histone acetylation.
Compton SE; Kitchen-Goosen SM; DeCamp LM; Lau KH; Mabvakure B; Vos M; Williams KS; Wong KK; Shi X; Rothbart SB; Krawczyk CM; Jones RG
Mol Cell; 2023 Jun; 83(11):1872-1886.e5. PubMed ID: 37172591
[TBL] [Abstract] [Full Text] [Related]
9. Acetylation regulates the nucleocytoplasmic distribution and oncogenic function of karyopherin alpha 2 in lung adenocarcinoma.
Feng HP; Liu YC; Wang CL; Liao WC; Yu JS; Yu CJ
Biochem Biophys Res Commun; 2023 Jun; 659():96-104. PubMed ID: 37060831
[TBL] [Abstract] [Full Text] [Related]
10. EGR1 induces EMT in pancreatic cancer via a P300/SNAI2 pathway.
Wang Y; Qin C; Zhao B; Li Z; Li T; Yang X; Zhao Y; Wang W
J Transl Med; 2023 Mar; 21(1):201. PubMed ID: 36932397
[TBL] [Abstract] [Full Text] [Related]
11. Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axis.
Guo XJ; Huang XY; Yang X; Lu JC; Wei CY; Gao C; Pei YZ; Chen Y; Sun QM; Cai JB; Zhou J; Fan J; Ke AW; Shi YG; Shen YH; Zhang PF; Shi GM; Yang GH
Cell Death Dis; 2023 Feb; 14(2):79. PubMed ID: 36732324
[TBL] [Abstract] [Full Text] [Related]
12. Efficacy and safety of different options for liver regeneration of future liver remnant in patients with liver malignancies: a systematic review and network meta-analysis.
Yi F; Zhang W; Feng L
World J Surg Oncol; 2022 Dec; 20(1):399. PubMed ID: 36527081
[TBL] [Abstract] [Full Text] [Related]
13. Estrone, the major postmenopausal estrogen, binds ERa to induce SNAI2, epithelial-to-mesenchymal transition, and ER+ breast cancer metastasis.
Qureshi R; Picon-Ruiz M; Sho M; Van Booven D; Nunes de Paiva V; Diaz-Ruano AB; Ince TA; Slingerland J
Cell Rep; 2022 Nov; 41(7):111672. PubMed ID: 36384125
[TBL] [Abstract] [Full Text] [Related]
14. Qualitative and quantitative parameters on hepatobiliary phase of gadoxetic acid-enhanced MR imaging for predicting pathological response to preoperative systemic therapy in colorectal liver metastases.
Gu XL; Cui Y; Wang K; Xing Q; Li XT; Zhu HT; Li ZW; Sun YS
Eur J Radiol; 2022 Dec; 157():110572. PubMed ID: 36327859
[TBL] [Abstract] [Full Text] [Related]
15. Protein succinylation associated with the progress of hepatocellular carcinoma.
Bai W; Cheng L; Xiong L; Wang M; Liu H; Yu K; Wang W
J Cell Mol Med; 2022 Nov; 26(22):5702-5712. PubMed ID: 36308411
[TBL] [Abstract] [Full Text] [Related]
16. Global crotonylome reveals hypoxia-mediated lamin A crotonylation regulated by HDAC6 in liver cancer.
Zhang D; Tang J; Xu Y; Huang X; Wang Y; Jin X; Wu G; Liu P
Cell Death Dis; 2022 Aug; 13(8):717. PubMed ID: 35977926
[TBL] [Abstract] [Full Text] [Related]
17. Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma.
Rimini M; Macarulla T; Burgio V; Lonardi S; Niger M; Scartozzi M; Rapposelli IG; Aprile G; Ratti F; Pedica F; Verdaguer H; Nappo F; Nichetti F; Lai E; Valgiusti M; Cappetta A; Febregat C; Fassan M; De Braud F; Puzzoni M; Frassineti GL; Simionato F; De Cobelli F; Aldrighetti L; Fornaro L; Cascinu S; Casadei-Gardini A
Eur J Cancer; 2022 Aug; 171():232-241. PubMed ID: 35749808
[TBL] [Abstract] [Full Text] [Related]
18. Safety, tolerability, and anti-fibrotic efficacy of the cbp/β-catenin inhibitor PRI-724 in patients with hepatitis C and B virus-induced liver cirrhosis: An investigator-initiated, open-label, non-randomised, multicentre, phase 1/2a study.
Kimura K; Kanto T; Shimoda S; Harada K; Kimura M; Nishikawa K; Imamura J; Ogawa E; Saio M; Ikura Y; Okusaka T; Inoue K; Ishikawa T; Ieiri I; Kishimoto J; Todaka K; Kamisawa T
EBioMedicine; 2022 Jun; 80():104069. PubMed ID: 35605429
[TBL] [Abstract] [Full Text] [Related]
19. Hepatoid carcinoma and related entities of the extrahepatic bile duct: A clinicopathological study of four cases.
Okura K; Esaki M; Nara S; Ban D; Takamoto T; Shimada K; Hiraoka N
Pathol Int; 2022 Jun; 72(6):332-342. PubMed ID: 35472251
[TBL] [Abstract] [Full Text] [Related]
20. Purine-Induced IFN-γ Promotes Uric Acid Production by Upregulating Xanthine Oxidoreductase Expression.
Wang H; Xie L; Song X; Wang J; Li X; Lin Z; Su T; Liang B; Huang D
Front Immunol; 2022; 13():773001. PubMed ID: 35154100
[TBL] [Abstract] [Full Text] [Related]
[Next]
